Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEP) Other Non-Current Liabilities (2021 - 2025)

Historic Other Non-Current Liabilities for Coeptis Therapeutics Holdings (COEP) over the last 5 years, with Q3 2025 value amounting to $409500.0.

  • Coeptis Therapeutics Holdings' Other Non-Current Liabilities rose 2712.46% to $409500.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $409500.0, marking a year-over-year increase of 2712.46%. This contributed to the annual value of $359250.0 for FY2024, which is 3553.16% down from last year.
  • Per Coeptis Therapeutics Holdings' latest filing, its Other Non-Current Liabilities stood at $409500.0 for Q3 2025, which was up 2712.46% from $467250.0 recorded in Q2 2025.
  • Over the past 5 years, Coeptis Therapeutics Holdings' Other Non-Current Liabilities peaked at $8.1 million during Q2 2021, and registered a low of $169125.0 during Q1 2025.
  • Moreover, its 5-year median value for Other Non-Current Liabilities was $557250.0 (2023), whereas its average is $1.7 million.
  • Per our database at Business Quant, Coeptis Therapeutics Holdings' Other Non-Current Liabilities plummeted by 9262.67% in 2022 and then skyrocketed by 23125.0% in 2023.
  • Coeptis Therapeutics Holdings' Other Non-Current Liabilities (Quarter) stood at $3.9 million in 2021, then plummeted by 70.87% to $1.1 million in 2022, then plummeted by 50.47% to $557250.0 in 2023, then tumbled by 35.53% to $359250.0 in 2024, then grew by 13.99% to $409500.0 in 2025.
  • Its last three reported values are $409500.0 in Q3 2025, $467250.0 for Q2 2025, and $169125.0 during Q1 2025.